Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. (Q39754801)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. |
scientific article |
Statements
1 reference
Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility of prostate cancer cells via inhibition of NF-kappaB. (English)
1 reference
Yeo Pyo Yun
1 reference
Sun Mi Kim
1 reference
So Yong Lee
1 reference
Jin Suk Cho
1 reference
Seung Mo Son
1 reference
Sang Sook Choi
1 reference
Hwan Soo Yoo
1 reference
Do Young Yoon
1 reference
Ki-Wan Oh
1 reference
Sang Bae Han
1 reference
Jin Tae Hong
1 reference
6 January 2010
1 reference
1 reference
631
1 reference
1-3
1 reference
1-9
1 reference
Identifiers
1 reference
1 reference